LASSO regression and WGCNA-based telomerase-associated lncRNA signaling predicts clear cell renal cell carcinoma prognosis and immunotherapy response.

ABSTRACT:

Objective

To investigate whether telomerase-associated lncRNA expression affects the prognosis and anti-tumor immunity of patients with renal clear cell carcinoma (ccRCC).

Methods

A series of analyses were performed to establish a prognostic risk model and validate its accuracy. Immune-related analyses were performed to assess further the association between immune status, tumor microenvironment, and prognostic risk models.

Results

Eight telomerase-associated lncRNAs associated with prognosis were identified and applied to establish a prognostic risk model. Overall survival was higher in the low-risk group.

Conclusion

The established prognostic risk model has a good predictive ability for the prognosis of ccRCC patients and provides a new possible therapeutic t

SUBMITTER: Shen C 

PROVIDER: S-EPMC11210217 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature